2025 Q4 Portfolio Activity
In 2025 Q4, ORACLE INVESTMENT MANAGEMENT INC maintained a portfolio of 28 distinct positions. The most significant new addition was TAYSHA GENE THERAPIES INC, now representing 0.87% of the total fund value. They heavily accumulated shares in ARDELYX INC, increasing the position by 24.5%. Conversely, ORACLE INVESTMENT MANAGEMENT INC completely exited their position in PALANTIR TECHNOLOGIES INC.
Position History
hover any row below to update
Loading…
Total Positions
28
Quarter
2025 Q4
Top Holding
WGS (68.5%)
Top 10 Concentration
94.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-28 of 28
ORACLE INVESTMENT MANAGEMENT INC Full Holdings List — 2025 Q4
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
WGS
GENEDX HOLDINGS...
|
Healthcare | 68.51% | 59.90% |
#1
Prev: #1
|
6.5 |
—
|
-5,300 | -0.6% |
P
S
|
884,654 | $115,058,099 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARDX
ARDELYX INC
|
Healthcare | 6.50% | 5.18% |
#2
1
Prev: #3
|
6.6 |
—
|
368,798 | 24.5% |
P
S
|
1,872,624 | $10,917,398 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 5.19% | 6.94% |
#3
1
Prev: #2
|
3.6 |
—
|
32,195 | 4.4% |
P
S
|
772,181 | $8,717,923 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
TELADOC HEALTH ...
|
|
CALL Option | 2.71% | 2.27% |
#4
5
Prev: #9
|
4.1 |
—
|
179,500 | 38.2% |
P
S
|
650,000 | $4,550,000 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CALL
NOVAVAX INC
|
|
CALL Option | 2.40% | — |
#5
Prev: #—
|
5.0 |
—
|
600,000 | — |
NEW
|
600,000 | $4,032,000 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CALL
ARDELYX INC
|
|
CALL Option | 2.08% | 2.18% |
#6
4
Prev: #10
|
1.3 |
—
|
-32,800 | -5.2% |
P
S
|
600,000 | $3,498,000 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
QDEL
QUIDELORTHO COR...
|
Healthcare | 2.01% | 2.18% |
#7
4
Prev: #11
|
1.8 |
—
|
no change | no change |
P
S
|
118,291 | $3,378,391 | 2004 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FORA
FORIAN INC
|
Healthcare | 1.72% | 1.92% |
#8
4
Prev: #12
|
1.7 |
—
|
no change | no change |
P
S
|
1,366,107 | $2,896,147 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PSNL
PERSONALIS INC
|
Healthcare | 1.61% | 0.93% |
#9
5
Prev: #14
|
3.1 |
—
|
109,908 | 47.9% |
P
S
|
339,343 | $2,701,170 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
BIOHAVEN LTD
|
|
CALL Option | 1.57% | 2.58% |
#10
3
Prev: #7
|
1.1 |
—
|
-42,100 | -15.3% |
P
S
|
232,900 | $2,629,441 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
TDOC
TELADOC HEALTH ...
|
Healthcare | 1.48% | 3.41% |
#11
6
Prev: #5
|
0.6 |
—
|
-351,078 | -49.8% |
P
S
|
354,338 | $2,480,366 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.87% | — |
#12
Prev: #—
|
3.8 |
—
|
265,000 | — |
NEW
|
265,000 | $1,457,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAVA
CAVA GROUP INC
|
Consumer Cyclical | 0.60% | 0.65% |
#13
2
Prev: #15
|
1.2 |
—
|
no change | no change |
P
S
|
17,100 | $1,003,599 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 0.57% | — |
#14
Prev: #—
|
3.7 |
—
|
38,343 | — |
NEW
|
38,343 | $951,482 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DAWN
DAY ONE BIOPHAR...
|
Healthcare | 0.55% | — |
#15
Prev: #—
|
3.7 |
—
|
100,000 | — |
NEW
|
100,000 | $932,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
PFIZER INC
|
|
CALL Option | 0.37% | — |
#16
Prev: #—
|
3.6 |
—
|
25,000 | — |
NEW
|
25,000 | $622,500 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
ARKG
ARK ETF TR
|
ETF | 0.34% | — |
#17
Prev: #—
|
3.6 |
—
|
19,500 | — |
NEW
|
19,500 | $564,915 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SGMO
SANGAMO THERAPE...
|
Healthcare | 0.26% | 0.42% |
#18
1
Prev: #17
|
0.6 |
—
|
31,018 | 3.1% |
P
S
|
1,035,742 | $435,012 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Healthcare | 0.25% | 0.21% |
#19
1
Prev: #18
|
1.1 |
—
|
no change | no change |
P
S
|
2,412 | $424,488 | 2004 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TEM
TEMPUS AI INC
|
Healthcare | 0.23% | — |
#20
Prev: #—
|
3.6 |
—
|
6,507 | — |
NEW
|
6,507 | $384,238 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSLA
TESLA INC
|
Consumer Cyclical | 0.13% | 0.14% |
#21
2
Prev: #19
|
1.1 |
—
|
no change | no change |
P
S
|
500 | $224,860 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HTZ
HERTZ GLOBAL HL...
|
Industrials | 0.05% | — |
#22
Prev: #—
|
3.5 |
—
|
15,000 | — |
NEW
|
15,000 | $77,100 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BDSX
BIODESIX INC
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-15,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KOID
KRANESHARES TRU...
|
Unknown | 0.00% | 0.45% |
Sold All 😨
(Was: #16) |
0.0 |
—
|
-22,400 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVAX
NOVAVAX INC
|
Healthcare | 0.00% | 1.32% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-243,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 0.00% | 2.46% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-110,300 | -100.0% |
CLOSED
|
— | $— | 2005 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PLTR
PALANTIR TECHNO...
|
Technology | 0.00% | 3.36% |
Sold All 😨
(Was: #6) |
0.0 |
—
|
-29,500 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
NOVAVAX INC
|
|
CALL Option | 0.00% | 3.44% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-635,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-28 of 28 holdings